Investor RelationsCOVID-19
  1. Home
  2. Medical Imaging
  3. Molecular Imaging
Biograph Vision

Molecular Imaging

Answering to clinical needs in oncology, neurology, cardiology, and radiology, Siemens Healthineers Molecular Imaging systems provide PET/CT, SPECT, and hybrid SPECT scanner (SPECT/CT) solutions to help clinicians diagnose, treat, and monitor disease more confidently.

Nuclear Medicine News & Stories

By Florian Bayer

Advances in PSMA-based approach for prostate cancer
 13.09.2022
Nuclear medicine, urology, and biomedical engineering experts discuss a new PSMA-based approach that combines diagnosis and therapeutics for the treatment of prostate cancer.
Healthcare Trends
Claudette Lew
SNMMI 2022 annual meeting showcases the future of nuclear medicine
 12.09.2022
Siemens Healthineers hosts booth and a luncheon symposium and launches new product at SNMMI 2022.
News

By Sameh Fahmy

A champion of PET innovation
 19.08.2022

An early PET advocate recounts the origins of PET implementation at RPA Hospital in Australia and today uses Biograph Vision Quadra.

Customer Experience

By Claudette Lew

Fortifying the foundation for personalized medicine
 11.07.2022
PETNET Solutions invests in its network to increase patient access to PET biomarkers and support future biomarker development.
Personalized Medicine

By Linda Brookes

Fully integrated SPECT/CT modernizes facilities to maximize abilities

 09.06.2022
Nuclear medicine experts on two continents describe how the new fully integrated SPECT/CT serves more patients and signals the beginning of a new era in nuclear imaging.
Customer Experience
* Biograph Vision is not commercially available in all countries. Due to regulatory reasons, its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.
1
syngo.PET Amyloid Plaque is intended for use only with approved amyloid radiopharmaceuticals in the country of use. Users should review the drug labeling for approved uses.